International Cannabis Weekly: 404

FIND OUT MORE ABOUT ECW »

COURT RULING AGAINST GERMAN ONLINE CANNABIS CLINIC SIGNALS LOOMING CRACKDOWN

Since the partial legalisation of cannabis in Germany, its status as a medicinal product has also changed significantly. Before the implementation of CanG last April, it remained difficult to find a doctor willing to support cannabis therapy, given the burdensome documentation required.

However, it has now become relatively easy to access medicinal cannabis for a wide range of conditions following the removal of cannabis from the list of narcotic substances.

READ MORE  »

COST VS CARE: CAN CLINICS STAY AFFORDABLE WHILE SCALING RESPONSIBLY?

READ MORE »

PHCANN CEO ON BUILDING EUROPE’S LARGEST CANNABIS SUPPLY CHAIN

READ MORE »

• As the UK’s medical cannabis industry continues its rapid advance, its future trajectory is becoming increasingly clear.
• UK cannabis industry voices concerns over further ACMD review delays, calling for clarity.
• Swiss cannabis trial has significantly disrupted black market activity in the nation.
• New scientific findings offer deeper insight into the function and therapeutic potential of the GPR55 receptor.
• German pharmacists have warned against cannabis sales via online platforms.
• The largest ever medical cannabis study in OCD patients shows major improvements.
• Ukraine has issued permits for the importation of medical cannabis as it advances industry.
• German court has made a new ruling which means that prisoners can legally possess cannabis in their cells.
• GrowGeneration expands product distribution into European and Costa Rican markets.
• Zoë Reece is currently on Kiwi trade mission to multibillion-dollar European market.
• Method Man’s TICAL partners with European e-commerce giant zamnesia for exclusive cannabis seed launch.
• At least 24 million European consumers consumed cannabis during the course of 2024.

GET VIP ACCESS»

SAVE ON BERLIN TICKETS »